GlaxoSmithKline Australia
Administration route: 
Vaccine group: 
Rotavirus vaccines

Registered for use in infants, with an upper age limit for dose 2 of 24 weeks. 

Live attenuated human rotavirus vaccine

Each 1.5 mL monodose pre-filled oral applicator or squeezable tube contains:

  • ≥106.0 cell culture infectious dose 50% (CCID50) of the RIX4414 human rotavirus strain, type G1P[8]
  • di-sodium adipate
  • Dulbecco’s modified Eagle medium
  • sterile water

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018